Abstract
As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Current Bioinformatics
Title: Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †
Volume: 7 Issue: 1
Author(s): Qiuli Liu, Xianping Guo and Tianshou Zhou
Affiliation:
Keywords: First passage model, generalized asynchronous probabilistic boolean network, optimal control, semi-markov decision process, gene network, therapeutic intervention policies, algorithm, dynamics, regulatory networks
Abstract: As a paradigm for modeling gene regulatory networks, synchronous or asynchronous probabilistic Boolean networks (PBNs) provide us an effective tool to design therapeutic intervention strategies. However, most of the previous works focused on the former and only few studied the latter. This paper deals with an optimal control problem in a generalized asynchronous PBN by applying the theory on semi-Markov decision processes. Specifically, we first formulate a control model for a generalized asynchronous PBN as a first passage model for semi-Markov decision processes and then solve the corresponding optimal control problem by choosing optimal constituent Boolean networks in the asynchronous PBN such that the risk probability that the first passage time to some undesirable states associated with disease does not exceed a certain time is minimal. Numerical simulations are also provided to demonstrate the effectiveness of the proposed optimality approach.
Export Options
About this article
Cite this article as:
Liu Qiuli, Guo Xianping and Zhou Tianshou, Optimal Control for Generalized Asynchronous Probabilistic Boolean Networks †, Current Bioinformatics 2012; 7 (1) . https://dx.doi.org/10.2174/157489312799304486
DOI https://dx.doi.org/10.2174/157489312799304486 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Tumor Detection Using Machine Learning and Deep Learning: A
Review
Current Medical Imaging Fruit as Potent Natural Antioxidants and Their Biological Effects
Current Pharmaceutical Biotechnology Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
Current Topics in Medicinal Chemistry The Coumarin Moiety as Chromophore of Fluorescent Ion Indicators in Biological Systems
Current Pharmaceutical Design Multiresolution Denoising for Optical Coherence Tomography: A Review and Evaluation
Current Medical Imaging Multitargeted Molecular Docking Study of Natural-Derived Alkaloids on Breast Cancer Pathway Components
Current Computer-Aided Drug Design Pharmacophore and 3D QSAR Study of TGFβ Inhibitors
Letters in Drug Design & Discovery A Sequence-based Approach for Predicting Protein Disordered Regions
Protein & Peptide Letters 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data
Inflammation & Allergy - Drug Targets (Discontinued) Safe and Convenient Fluorescent Stain Imager for Proteome Analysis
Current Proteomics Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine Biological Nitration of Arachidonic Acid
Current Vascular Pharmacology Facile Microwave-Assisted Synthesis and Pharmacological Appraisal of Bioactive Dihydropyrimidinone Derivatives
Current Microwave Chemistry Encapsulation of Metal and Metal Oxide Nanoparticles by Nutraceuticals: Implications for Biological Activities
Current Nutraceuticals Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine HDL Genetic Defects
Current Pharmaceutical Design Obesity and Inflammation: Colorectal Cancer Engines
Current Molecular Pharmacology Simultaneous Electrochemical Determination of Vitamin K1 and Vitamin D3 by using Poly (Alizarin Red S)/Multi-walled Carbon Nanotubes Modified Glassy Electrode
Current Analytical Chemistry Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews